WHO expert committee on biological standardization / World Health Organization
Material type:
- 9789241209786
- HV 5825 .W46 2013

Item type | Current library | Home library | Collection | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|---|
![]() |
National University - Manila | LRC - Main General Circulation | Pharmacy | GC HV 5825 .W46 2013 (Browse shelf(Opens below)) | c.1 | Available | NULIB000013675 |
Browsing LRC - Main shelves, Shelving location: General Circulation, Collection: Pharmacy Close shelf browser (Hides shelf browser)
![]() |
![]() |
No cover image available |
![]() |
![]() |
![]() |
No cover image available | ||
GC HD 9666.5 .E45 2012 Pharmaceutical lifecycle management : making the most of each and every brand / | GC HD 9672.I52 .C46 2009 The Rx factor : strategic creativity in pharmaceutical marketing / | GC HG 1601 .F76 2004 The Bank analyst's handbook : money, risk and conjuring tricks / | GC HV 5825 .W46 2013 WHO expert committee on biological standardization / | GC KF 2915.P452 .S77 2012 Essentials of law and ethics for pharmacy technicians / | GC KF 3821 .N48 2019 Legal and ethical issues for health profession / | GC Q 175.5 .B75 1998 Science, technology, and society : an introduction / |
Includes bibliographical references.
1. Introduction -- 2. General -- 3. International Recommendations, Guidelines and other matters related to the manufacture and quality control of biologicals -- 4. International reference materials-vaccines and related substances -- 5. International reference materials-blood products and related substances -- 6. International reference materials-diagnostic reagents -- 7. International reference materials-biotherapeutics (other than blood products) -- 8. International reference materials-antibiotics -- References -- Annex 1 to Annex 7/
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biologicals and the establishment of international biological reference materials. The report starts with a discussion of general issues brought to the attention of the Committee and provides information on the status and development of reference materials for various antibodies, antigens, blood products and related substances, cytokines, growth factors, endocrinological substances and in vitro diagnostic devices. The second part of the report, of particular relevance to manufacturers and national regulatory authorities, contains revised WHO recommendations for evaluation of animal-cell cultures as substrates for the manufacture of biological medicinal products, for production and control of hepatitis B vaccines and for production and control of yellow fever vaccines. New WHO guidelines on the independent lot release of vaccines are also included. Finally, there is an update to the procedure for the prequalification of vaccines. Also included are lists of recommendations, guidelines and other documents related to the manufacture and control of biological substances used in medicine, and of International Standards and Reference Reagents for biological substances.
There are no comments on this title.